Repeatability and reproducibility of the hyperinsulinemic-euglycemic clamp and the tracer dilution technique in a controlled inpatient setting

Metabolism: Clinical and Experimental

Volumn 58, Issue 3, 2009, Pages 304-310

  Le, Duc Son N T ^a   Brookshire, Thomas ^a   Krakoff, Jonathan ^a   Bunt, Joy C ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; TRACER;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL EVALUATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DILUTION; DOUBLE BLIND PROCEDURE; GLUCOSE BLOOD LEVEL; HOSPITAL PATIENT; HUMAN; HYPERINSULINEMIA; INSULIN RELEASE; MALE; MEASUREMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REPRODUCIBILITY; STEADY STATE;

ABSORPTIOMETRY, PHOTON; ADIPOSE TISSUE; ADULT; ANIMALS; BODY COMPOSITION; CROSS-OVER STUDIES; DIET; DOUBLE-BLIND METHOD; GLUCOSE CLAMP TECHNIQUE; GLUCOSE INTOLERANCE; HUMANS; HYPERINSULINISM; INPATIENTS; INSULIN; INSULIN RESISTANCE; MALE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SWINE; YOUNG ADULT;

EID: 59649102470     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2008.09.029     Document Type: Article

References (36)

1. Matthaei S., Stumvoll M., Kellerer M., et al. Pathophysiology and pharmacological treatment of insulin resistance. Endocr Rev 21 (2000) 585-618
2. van Stralen K.J., Jager K.J., Zoccali C., et al. Agreement between methods. Kidney Int 74 (2008) 1116-1120
3. Reneland R., Andren B., Lind L., et al. Circulating angiotensin converting enzyme levels are increased in concentric, but not eccentric, left ventricular hypertrophy in elderly men. J Hypertens 15 (1997) 885-890
4. Soop M., Nygren J., Brismar K., et al. The hyperinsulinaemic-euglycaemic glucose clamp: reproducibility and metabolic effects of prolonged insulin infusion in healthy subjects. Clin Sci (Lond) 98 (2000) 367-374
5. Bokemark L., Froden A., Attvall S., et al. The euglycemic hyperinsulinemic clamp examination: variability and reproducibility. Scand J Clin Lab Invest 60 (2000) 27-36
6. DeFronzo R.A., Tobin J.D., and Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237 (1979) E214-E223
7. Mantha S., Roizen M.F., Fleisher L.A., et al. Comparing methods of clinical measurement: reporting standards for Bland and Altman analysis. Anesth.Analg. 90 (2000) 593-602
8. Bland J.M., and Altman D.G. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1 (1986) 307-310
9. Bland J.M., and Altman D.G. Measuring agreement in method comparison studies. Stat Methods Med Res 8 (1999) 135-160
10. Hother-Nielsen O., Henriksen J.E., Holst J.J., et al. Effects of insulin on glucose turnover rates in vivo: isotope dilution versus constant specific activity technique. Metabolism 45 (1996) 82-91
11. Finegood D.T., Bergman R.N., and Vranic M. Estimation of endogenous glucose production during hyperinsulinemic-euglycemic glucose clamps. Comparison of unlabeled and labeled exogenous glucose infusates. Diabetes 36 (1987) 914-924
12. Tataranni P.A., and Ravussin E. Use of dual-energy X-ray absorptiometry in obese individuals. Am J Clin Nutr 62 (1995) 730-734
13. Genuth S., Alberti K.G., Bennett P., et al. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 26 (2003) 3160-3167
14. Bogardus C., Lillioja S., and Bennett P.H. Pathogenesis of NIDDM in Pima Indians. Diabetes Care 14 (1991) 685-690
15. Bogardus C., Lillioja S., Howard B.V., et al. Relationships between insulin secretion, insulin action, and fasting plasma glucose concentration in nondiabetic and noninsulin-dependent diabetic subjects. J Clin Invest 74 (1984) 1238-1246
16. Lillioja S., Mott D.M., Spraul M., et al. Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians. N Engl J Med 329 (1993) 1988-1992
17. Steele R. Influences of glucose loading and of injected insulin on hepatic glucose output. Ann N Y Acad Sci 82 (1959) 420-430
18. Lillioja S., and Bogardus C. Obesity and insulin resistance: lessons learned from the Pima Indians. Diabetes Metab Rev 4 (1988) 517-540
19. Frandsen H.A., Snitker S., Christensen N.J., et al. No differential effects of porcine and human insulin on muscle sympathetic nerve activity during euglycaemia or hypoglycaemia. Clin Physiol 16 (1996) 9-21
20. Heine R.J., van der Heyden E.A., and van der Veen E.A. Responses to human and porcine insulin in healthy subjects. Lancet 2 (1989) 946-949
21. Home P.D., Shepherd G.A., Noy G., et al. Comparison of the activity and pharmacokinetics of porcine insulin and human insulin (Novo) as assessed by the glucose clamp technique in normal and diabetic man. Diabetes Care 6 Suppl 1 (1983) 23-28
22. Howey D.C., Fineberg S.E., Nolen P.A., et al. The therapeutic efficacy of human insulin (recombinant DNA) in patients with insulin-dependent diabetes mellitus: a comparative study with purified porcine insulin. Diabetes Care 5 Suppl 2 (1982) 73-77
23. Kern W., Lieb K., Kerner W., et al. Differential effects of human and pork insulin-induced hypoglycemia on neuronal functions in humans. Diabetes 39 (1990) 1091-1098
24. Lingenfelser T., Renn W., Plonz C., et al. Catecholamine response during human and pork insulin-induced hypoglycemia in IDDM patients. Diabetes Care 15 (1992) 261-264
25. Owens D.R., Jones M.K., Hayes T.M., et al. Human insulin: study of safety and efficacy in man. Br Med J (Clin Res Ed) 282 (1981) 1264-1266
26. Staten M., Worcester B., Szekeres A., et al. Comparison of porcine and semisynthetic human insulins using euglycemic clamp-derived glucose-insulin dose-response curves in insulin-dependent diabetes. Metabolism 33 (1984) 132-135
27. Katz H., Butler P., Homan M., et al. Hepatic and extrahepatic insulin action in humans: measurement in the absence of non-steady-state error. Am J Physiol 264 (1993) E561-E566
28. Imperatore G., Cheng Y.J., Williams D.E., et al. Physical activity, cardiovascular fitness, and insulin sensitivity among U.S. adolescents: the National Health and Nutrition Examination Survey, 1999-2002. Diabetes Care 29 (2006) 1567-1572
29. Mayer-Davis E.J., D'Agostino Jr. R., Karter A.J., et al. Intensity and amount of physical activity in relation to insulin sensitivity: the Insulin Resistance Atherosclerosis Study. JAMA 279 (1998) 669-674
30. Hamburg N.M., McMackin C.J., Huang A.L., et al. Physical inactivity rapidly induces insulin resistance and microvascular dysfunction in healthy volunteers. Arterioscler Thromb Vasc Biol (2007)
31. Riserus U., Arnlov J., and Berglund L. Long-term predictors of insulin resistance: role of lifestyle and metabolic factors in middle-aged men. Diabetes Care 30 (2007) 2928-2933
32. Lakka T.A., and Salonen J.T. Physical activity and serum lipids: a cross-sectional population study in eastern Finnish men. Am J Epidemiol 136 (1992) 806-818
33. Palaniappan L.P., Kwan A.C., Abbasi F., et al. Lipoprotein abnormalities are associated with insulin resistance in South Asian Indian women. Metabolism 56 (2007) 899-904
34. Fruehwald-Schultes B., Oltmanns K.M., Kern W., et al. The effect of experimentally induced insulin resistance on the leptin response to hyperinsulinaemia. Int J Obes Relat Metab Disord 26 (2002) 510-516
35. Anderwald C., Bernroider E., Krssak M., et al. Effects of insulin treatment in type 2 diabetic patients on intracellular lipid content in liver and skeletal muscle. Diabetes 51 (2002) 3025-3032
36. Doberne L., Greenfield M.S., Schulz B., et al. Enhanced glucose utilization during prolonged glucose clamp studies. Diabetes 30 (1981) 829-835